Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 08 Dec 2023

Extracellular vesicles from adipose stem cells ameliorate allergic rhinitis in mice by immunomodulatory

in Cancer Immunity and Immunotherapy

Wenhan Yang
Zhiyu Pan
Jiacheng Zhang
Lian Wang
Ju lai
Shican Zhou
Zhili Zhang
Kai Fan
Dan Deng
Zhengliang Gao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1302336

7,316 views
5 citations

Review

Published on 08 Dec 2023

The regulatory effect of growth differentiation factor 11 on different cells

in Cancer Immunity and Immunotherapy

Yingchun Shao
Ting Liu
Xiaobo Wen
Renshuai Zhang
Xinlin Liu
Dongming Xing

Frontiers in Immunology

doi 10.3389/fimmu.2023.1323670

3,673 views
4 citations

Brief Research Report

Published on 08 Dec 2023

Rank aggregation of independent genetic screen results highlights new strategies for adoptive cellular transfer therapy of cancer

in Cancer Immunity and Immunotherapy

Vianca V. Vianzon
Rylee M. Hanson
Ishita Garg
Gwenyth J. Joseph
Laura M. Rogers

Frontiers in Immunology

doi 10.3389/fimmu.2023.1235131

2,166 views

Original Research

Published on 08 Dec 2023

Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma

in Cancer Immunity and Immunotherapy

Heng Wang
Wei Wang
Zhen Wang
Xu Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1291859

4,460 views
2 citations

Review

Published on 08 Dec 2023

Progress and challenges of plant-derived nucleic acids as therapeutics in macrophage-mediated RNA therapy

in Cancer Immunity and Immunotherapy

Yu-Da Liu
Hao-Ran Chen
Yao Zhang
Ge Yan
Hao-Jie Yan
Qi Zhu
Li-Hua Peng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1255668

4,153 views
6 citations

Original Research

Published on 08 Dec 2023

HER2 positivity predicts BCG unresponsiveness and adaptive immune cell exhaustion in EORTC risk-stratified cohort of bladder cancer

in Cancer Immunity and Immunotherapy

Wook Nam
Han Kyu Chae
Yeonuk Jung
Homin Kang
Myungchan Park
Ahnryul Choi
Jong Yeon Park
Dae-Woon Eom
Sung Jin Kim

Frontiers in Immunology

doi 10.3389/fimmu.2023.1301510

3,356 views
3 citations

Case Report

Published on 08 Dec 2023

Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab – a case report

in Cancer Immunity and Immunotherapy

Simon Fietz
Anne Fröhlich
Cornelia Mauch
Luka de Vos-Hillebrand
Tanja Fetter
Jennifer Landsberg
Friederike Hoffmann
Judith Sirokay

Frontiers in Immunology

doi 10.3389/fimmu.2023.1324231

2,015 views
5 citations

Original Research

Published on 08 Dec 2023

Correlation of endoplasmic reticulum stress patterns with the immune microenvironment in hepatocellular carcinoma: a prognostic signature analysis

in Cancer Immunity and Immunotherapy

Ke Zhan
Xin Yang
Shuang Li
Yang Bai

Frontiers in Immunology

doi 10.3389/fimmu.2023.1270774

2,461 views
3 citations

Case Report

Published on 08 Dec 2023

Case Report: CD19 CAR T-cell therapy following autologous stem cell transplantation: a successful treatment for R/R CD20-negative transformed follicular lymphoma with TP53 mutation

in Cancer Immunity and Immunotherapy

Jinjing Zhang
Dali Cai
Ran Gao
Yuan Miao
Yan Cui
Zhenghua Liu
Heyang Zhang
Xiaojing Yan
Nan Su

Frontiers in Immunology

doi 10.3389/fimmu.2023.1307242

4,319 views
4 citations

Case Report

Published on 08 Dec 2023

Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma

in Cancer Immunity and Immunotherapy

Wei Mu
Meilan Zhang
Guang Hu
Yunfeng Han
Xia Mao
Caixia Chen
Kefeng Shen
Zhenyu Dai
Xiaojian Zhu
Xiaoxi Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2023.1280007

3,057 views
2 citations

Review

Published on 07 Dec 2023

Roles of tissue-resident immune cells in immunotherapy of non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Rui Tang
Haitao Wang
Mingxi Tang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1332814

3,230 views
5 citations

Original Research

Published on 07 Dec 2023

Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses

in Cancer Immunity and Immunotherapy

Yaping Guo
Siyu Li
Chentan Li
Li Wang
Wanshan Ning

Frontiers in Immunology

doi 10.3389/fimmu.2023.1326018

3,928 views
2 citations

Original Research

Published on 07 Dec 2023

Overexpression of MTHFD2 represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer

in Cancer Immunity and Immunotherapy

Xiaokai Shi
Xiangrong Peng
Yin Chen
Zebin Shi
Chuang Yue
Li Zuo
Lifeng Zhang
Shenglin Gao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1326509

3,572 views
3 citations

Review

Published on 07 Dec 2023

CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer

in Cancer Immunity and Immunotherapy

Fatemeh Nasiri
Khadijeh Farrokhi
Pouya Safarzadeh Kozani
Maral Mahboubi Kancha
Setareh Dashti Shokoohi
Pooria Safarzadeh Kozani

Frontiers in Immunology

doi 10.3389/fimmu.2023.1302307

7,141 views
9 citations

Brief Research Report

Published on 07 Dec 2023

KLF14 activates the JNK-signaling pathway to induce S-phase arrest in cervical cancer cells

in Cancer Immunity and Immunotherapy

Ying Du
Hui Ye
Mei Lin
Lili Cao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1267950

4,197 views

Review

Published on 07 Dec 2023

ROS regulation in gliomas: implications for treatment strategies

in Cancer Immunity and Immunotherapy

Yu-Chen Yang
Yu Zhu
Si-Jia Sun
Can-Jun Zhao
Yang Bai
Jin Wang
Li-Tian Ma

Frontiers in Immunology

doi 10.3389/fimmu.2023.1259797

7,895 views
19 citations